杜皮卢马布减少了慢性阻塞性肺病和肺气患者的恶化并改善了肺功能:3期随机试验 (BOREAS)
Surya P Bhatt1, Klaus F Rabe2, Nicola A Hanania3
1Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Respiratory medicine
|October 31, 2024
概括
在患有慢性阻塞性肺病 (COPD) 和2型炎症的患者中,杜皮卢马布有效降低了恶化并改善了肺功能. 治疗表现出类似的疗效,无论患者是否患有肺气.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种严重的呼吸系统疾病.
- 2型炎症在某些COPD表型中起作用.
- 杜皮卢马布向的是介素-4和介素-13通路.
研究的目的:
- 为了评估dupilumab在患有2型炎症的COPD患者中的疗效.
- 根据肺气的存在或不存在来评估临床结果.
主要方法:
- 第3期BOREAS试验涉及COPD患者的2型炎症 (血液中乙素≥300细胞/μL).
- 患者在52周内接受了补充杜皮卢马布 (300毫克每2周一次) 或安慰剂.
- 测量结果:年均中度/重度COPD恶化率和12周前1秒内前支气管扩展剂强迫呼吸量 (FEV1) 的变化.
主要成果:
- 与安慰剂相比,dupilumab在肺瘤和非肺瘤组中减少了29-31%的恶化率.
- 在双卢马布治疗的两组中,观察到前支气管扩展剂FEV1的改善.
- 对于恶化或FEV1.1,没有发现乳瘤状态对dupilumab疗效的显著相互作用效应.
结论:
- 杜皮卢马布在减少COPD恶化和改善肺功能方面表现出一致的有效性.
- 在患有2型炎症的COPD患者中,杜皮卢马布的益处是可比的,不论肺气是否存在.
- 杜皮卢马布是COPD患者的潜在治疗选择,患者有2型炎症和肺气.
关键词:
体重指数 (BMI) 体重指数 (BMI) 体重指数 (BMI) 体重指数 (BMI) 体重指数 (BMI)慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性慢性肺炎.杜比卢马布 (Dupilumab) 的使用情况突发性瘤是什么意思埃索诺菲尔细胞是什么意思恶化的情况加剧.这是一种2型炎症.更多相关视频
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
234
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
234
01:17Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K